Top Markets
Coin of the day
Applied Molecular Transport Inc. Applied Molecular Transport Inc.

Applied Molecular Transport Inc.

AMTI
Classifica tra le azioni #32736
Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the... Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California. The firm is dedicated to discovering and advancing a pipeline of oral and respiratory biologic drug candidates, designed to address a variety of medical conditions including autoimmune, inflammatory, and metabolic diseases. Among its investigational treatments, AMT-101 stands out as the lead candidate. This orally administered, gastrointestinal (GI)-selective biologic, derived from rhIL-10, is presently in Phase II clinical trials for the management of ulcerative colitis and other related inflammatory indications. AMTI is also further developing AMT-126, another oral, GI-selective biologic that harnesses interleukin 22. This compound is currently undergoing Phase I clinical studies for the treatment of disorders stemming from impaired intestinal epithelial barrier function. The company's innovative technology platform allows for the creation and development of a broad spectrum of oral biologic therapeutic approaches, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics.
Prezzo delle azioni
$0.263
Ultima sincronizzazione: 2023-12-29
Capitalizzazione di mercato
$9.26M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Applied Molecular Transport Inc. (AMTI)

Categoria

Utile per Applied Molecular Transport Inc. (AMTI)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Applied Molecular Transport Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Applied Molecular Transport Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$5.27B -
US
$1.95B -
NL
- -
CH
- -
KR
$3.01B -
BE